- Nachrichtendetail
-
09.07.2024 17:00:16 - dpa-AFX: Pfizer Chief Scientific Officer Mikael Dolsten To Step Down
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE), Tuesday announced that Mikael
Dolsten will step down from the role of Chief Scientific Officer, and President,
Pfizer Research & Development.
The drug manufacturer also stated that Dolsten will continue to serve in his
current position until a successor is appointed.
To identify a new chief scientific officer, Pfizer will initiate an external
search which is expected to last through early next year.
Currently, Pfizer's stock is moving down 1.84 percent, to $ 27.42 on the New
York Stock Exchange.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Dolsten will step down from the role of Chief Scientific Officer, and President,
Pfizer Research & Development.
The drug manufacturer also stated that Dolsten will continue to serve in his
current position until a successor is appointed.
To identify a new chief scientific officer, Pfizer will initiate an external
search which is expected to last through early next year.
Currently, Pfizer's stock is moving down 1.84 percent, to $ 27.42 on the New
York Stock Exchange.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 29,520 | 23.07.24 19:53:40 | -0,080 | -0,27% | 29,520 | 29,530 | 30,110 | 29,600 |
